Back to Results
First PageMeta Content
Pharmaceutical industry / Epidemiology / Health promotion / Health policy / Clinical trial / Chronic / National Health and Medical Research Council / Public health / Health / Medicine / Clinical research


Chronic illness: economic risks for families, government and the economy and approaches to reducing risk The Society for Risk Analysis (Australia and New Zealand) International Conference, the Crawford School of Public P
Add to Reading List

Document Date: 2013-10-28 01:08:23


Open Document

File Size: 459,63 KB

Share Result on Facebook

Company

Pfizer Australia / /

Country

Australia / New Zealand / /

Currency

USD / /

Facility

University of Sydney Dr Rupendra Shrestha / NHMRC Clinical Trials Centre University of Sydney / Australian National University / University of Canberra / Pfizer Australia NHMRC Clinical Trials Centre University of Sydney / NHMRC Clinical Trials Centre University of Sydney Health / University of Sydney / The University of Queensland / /

MedicalCondition

Chronic / Chronic illness / pain / chronic disease / e.g. diabetes / chronic conditions / /

Organization

School of Public Health / University of Queensland / University of Sydney / Society for Risk Analysis / NHMRC Clinical Trials Centre / NHMRC Clinical Trials Centre University of Sydney Health / Centre for Burden of Disease and Cost-Effectiveness / Australian Government / Australian National University / Canberra / Crawford School of Public Policy / NHMRC Clinical Trials Centre University of Sydney / University of Canberra / /

Person

Emily Callander / Melanie Bertram / Deborah Schofield / Megan Passey / Richard Percival / Theo Vos / Simon Kelly / /

Position

Professor / Chair / Associate Professor / Chair of Health Economics / /

ProvinceOrState

Queensland / /

PublishedMedium

Health Economics / /

SocialTag